Cargando…

Reasons for not initiating osteoporosis therapy among a managed care population

BACKGROUND: Many women with osteoporosis do not initiate osteoporosis treatment. OBJECTIVE: To examine patients’ reasons for not initiating osteoporosis treatment among women with osteoporosis. METHODS: Survey recipients were identified from a national US claims database and included women ≥55 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jingbo, Brenneman, Susan K, Sazonov, Vasilisa, Modi, Ankita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480594/
https://www.ncbi.nlm.nih.gov/pubmed/26150702
http://dx.doi.org/10.2147/PPA.S81963
_version_ 1782378169239601152
author Yu, Jingbo
Brenneman, Susan K
Sazonov, Vasilisa
Modi, Ankita
author_facet Yu, Jingbo
Brenneman, Susan K
Sazonov, Vasilisa
Modi, Ankita
author_sort Yu, Jingbo
collection PubMed
description BACKGROUND: Many women with osteoporosis do not initiate osteoporosis treatment. OBJECTIVE: To examine patients’ reasons for not initiating osteoporosis treatment among women with osteoporosis. METHODS: Survey recipients were identified from a national US claims database and included women ≥55 years with an osteoporosis diagnosis from January 1, 2010 to March 31, 2012 as defined by: 1) osteoporosis diagnosis coupled with bone mineral density test within 183 days of diagnosis and/or 2) osteoporosis-related fracture. Eligibility required no claims for osteoporosis medication 1) at least 12 months and up to 5 years prior to osteoporosis diagnosis and 2) at least 6 months after osteoporosis diagnosis. Continuous enrollment for 18 months (6 months pre-osteoporosis and 12 months post-osteoporosis diagnosis) was also required. A total of 2,000 patients with the most recent osteoporosis diagnosis were mailed a survey. Respondents reporting that they did not initiate physician-recommended osteoporosis medication, after either their physician told them they had osteoporosis or they experienced a fracture since age 45 years, were asked for reasons why they did not initiate treatment. RESULTS: There were 430 patients who returned a complete survey; mean age was 61% and 21.6% had a fracture. A total of 197 (45.8%) patients reported their physician diagnosed osteoporosis and 117 (59.3%) of those were recommended osteoporosis medication; 44 of the 117 patients (37.6%) did not initiate recommended osteoporosis medication by the time of survey. The primary reasons for not initiating osteoporosis medication were concern over side effects (77.3%), medication costs (34.1%), and pre-existing gastrointestinal concerns (25.0%). CONCLUSION: Among respondents, 41% of patients whose physician diagnosed osteoporosis were not recommended osteoporosis treatment and 38% of patients who were recommended osteoporosis treatment did not initiate treatment within approximately 2 years of diagnosis. Concerns with side effects of osteoporosis treatment, medication costs, and pre-existing gastrointestinal concerns were the most common reasons for not initiating recommended treatment.
format Online
Article
Text
id pubmed-4480594
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44805942015-07-06 Reasons for not initiating osteoporosis therapy among a managed care population Yu, Jingbo Brenneman, Susan K Sazonov, Vasilisa Modi, Ankita Patient Prefer Adherence Original Research BACKGROUND: Many women with osteoporosis do not initiate osteoporosis treatment. OBJECTIVE: To examine patients’ reasons for not initiating osteoporosis treatment among women with osteoporosis. METHODS: Survey recipients were identified from a national US claims database and included women ≥55 years with an osteoporosis diagnosis from January 1, 2010 to March 31, 2012 as defined by: 1) osteoporosis diagnosis coupled with bone mineral density test within 183 days of diagnosis and/or 2) osteoporosis-related fracture. Eligibility required no claims for osteoporosis medication 1) at least 12 months and up to 5 years prior to osteoporosis diagnosis and 2) at least 6 months after osteoporosis diagnosis. Continuous enrollment for 18 months (6 months pre-osteoporosis and 12 months post-osteoporosis diagnosis) was also required. A total of 2,000 patients with the most recent osteoporosis diagnosis were mailed a survey. Respondents reporting that they did not initiate physician-recommended osteoporosis medication, after either their physician told them they had osteoporosis or they experienced a fracture since age 45 years, were asked for reasons why they did not initiate treatment. RESULTS: There were 430 patients who returned a complete survey; mean age was 61% and 21.6% had a fracture. A total of 197 (45.8%) patients reported their physician diagnosed osteoporosis and 117 (59.3%) of those were recommended osteoporosis medication; 44 of the 117 patients (37.6%) did not initiate recommended osteoporosis medication by the time of survey. The primary reasons for not initiating osteoporosis medication were concern over side effects (77.3%), medication costs (34.1%), and pre-existing gastrointestinal concerns (25.0%). CONCLUSION: Among respondents, 41% of patients whose physician diagnosed osteoporosis were not recommended osteoporosis treatment and 38% of patients who were recommended osteoporosis treatment did not initiate treatment within approximately 2 years of diagnosis. Concerns with side effects of osteoporosis treatment, medication costs, and pre-existing gastrointestinal concerns were the most common reasons for not initiating recommended treatment. Dove Medical Press 2015-06-19 /pmc/articles/PMC4480594/ /pubmed/26150702 http://dx.doi.org/10.2147/PPA.S81963 Text en © 2015 Yu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Yu, Jingbo
Brenneman, Susan K
Sazonov, Vasilisa
Modi, Ankita
Reasons for not initiating osteoporosis therapy among a managed care population
title Reasons for not initiating osteoporosis therapy among a managed care population
title_full Reasons for not initiating osteoporosis therapy among a managed care population
title_fullStr Reasons for not initiating osteoporosis therapy among a managed care population
title_full_unstemmed Reasons for not initiating osteoporosis therapy among a managed care population
title_short Reasons for not initiating osteoporosis therapy among a managed care population
title_sort reasons for not initiating osteoporosis therapy among a managed care population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480594/
https://www.ncbi.nlm.nih.gov/pubmed/26150702
http://dx.doi.org/10.2147/PPA.S81963
work_keys_str_mv AT yujingbo reasonsfornotinitiatingosteoporosistherapyamongamanagedcarepopulation
AT brennemansusank reasonsfornotinitiatingosteoporosistherapyamongamanagedcarepopulation
AT sazonovvasilisa reasonsfornotinitiatingosteoporosistherapyamongamanagedcarepopulation
AT modiankita reasonsfornotinitiatingosteoporosistherapyamongamanagedcarepopulation